bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.05.15.594103

In silico model suggests that interdigitation promotes robust activation of atrial cells by pacemaker cells

Abstract

The heartbeat is initiated by electrical pulses generated by a specialized patch of cells called the sinoatrial node (SAN), located on top of the right upper chamber, and then passed on to the atrium. Cardiac arrhythmias may arise if these electrical pulses fail to propagate toward the atrial cells. This computational modeling study asks how the morphology of the interface between sinoatrial (pacemaker) cells and atrial cells can influence the robustness of pulse propagation. Due to its strong negative potential, the atrium may suppress the pacemaker activity of the SAN if the electrical coupling between atrial cells is too strong. If the electrical coupling is too weak, however, the pacemaker cells cannot activate the atrial cells due to a source-sink mismatch. The SAN and atrium are connected through interdigitating structures, which are believed to contribute to the robustness of action potentials and potentially solve this trade-off. Here we investigate this interdigitation hypothesis using a hybrid model, integrating the cellular Potts model (CPM) for cellular morphology and partial-differential equations-based electrophysiological models for pulse propagation. Systematic examination of interdigitation patterns revealed that a symmetric geometry with medium-sized protrusions can prevent exit blocks. We conclude that interdigitation of SAN cells and atrial cells can promote robust propagation of action potentials toward the atrial tissue but only if the protrusions are of sufficient size and synchronicity of the action potential wave is maintained due to symmetry. This study not only highlights essential design principles for in vitro models of cardiac arrhythmias, but also provides insights into the occurrence of exit blocks in vivo. Author summaryOur hearts beat automatically and robustly. This autonomous heartbeat is initiated by electrical pulses generated by a specialized patch of cells called the sinoatrial node, located on top of the right upper chamber. These pulses can be interpreted as electrical signals that allow the heart muscle to contract. The heart muscle cells surrounding the sinoatrial node tend to hinder this spontaneous activation because of a mismatch in electrical properties. Therefore, the pacemaker cells must be sufficiently electrically insulated from their surroundings. However, full insulation of the pacemaker cells would hinder propagation of the activation pulse toward the rest of the heart. A common hypothesis is that the sinoatrial node is fully insulated, except for some specialized pathways. We have studied the arrangement of different cell types within these pathways with the central question: how should the sinoatrial node and atrium be connected to ensure robust propagation of the electrical pulse? We implemented a computational model inspired by in vitro experimental setups and found several relevant mechanisms. For example, we found that a folding-finger-like structure between the cell types can dramatically improve the robustness of action potentials propagating in such a tissue, provided that the folds do not become too small. This study may help improve design of in vitro models of sinoatrial node diseases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

de Jong, M. A., Merks, R. M. H.. 2024-05-17. In silico model suggests that interdigitation promotes robust activation of atrial cells by pacemaker cells. https://doi.org/10.1101/2024.05.15.594103

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology↗

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology↗

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology↗